Vice President M Venkaiah Naidu Saturday stressed the need to make world class drugs available at affordable prices, with thrust on research and innovation.
"There should be an unwavering commitment to high standards of quality in drug manufacturing and quality frameworks such as Good Manufacturing Practices should strictly be adhered to," he said.
Addressing the second decennial celebrations of Sarojini Naidu Vanita Pharmacy Maha Vidyalaya in Hyderabad, he called for a thrust on research and innovation.
The Vice President said new healthcare challenges were emerging every day, especially with the alarming rise in the number of non-communicable and lifestyle diseases and cancers.
"New molecules and new drugs will have to be discovered and treatment protocols will have to be continuously upgraded and updated. All this will have to be achieved without compromising on the affordability of drugs," he said.
While major multinationals and pharma companies would be interested in producing and selling drugs that cater to common and chronic diseases affecting larger populations, there was a need to develop new molecules and drugs to combat lesser known diseases, particularly the group called 'rare diseases', affecting more than 70 million people in India, he said.
While it is estimated that there are around 7,000 rare diseases in the world, most diseases have no treatment and the costs are prohibitively expensive in cases where they are available, he said
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
